General description
INN
Erlotinib
ATC codes
Medicine type
Chemical agent
EML status history
Application rejected in 2017
(TRS
1006)
for
Other specified malignant neoplasms of bronchus or lung
Added in 2019
(TRS
1021)
for
Other specified malignant neoplasms of bronchus or lung
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Oral > Solid: 100 mg; 150 mg